Tacrolimus for AIHA

Overview
Tacrolimus is a generic prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe atopic dermatitis in children and adults. Tacrolimus is sometimes prescribed off-label to treat autoimmune hemolytic anemia (AIHA). Tacrolimus can be found under the brand names Astagraf XL, Envarsus XR, Hecoria, and Prograf.

Tacrolimus is an immunosuppressant, a drug that suppresses the immune system. It is believed that tacrolimus works in cases of psoriasis by controlling inflammation.

How do I take it?
Tacrolimus is available as an oral pill and an injectable. Doses vary, so always follow your doctor’s instructions exactly when using tacrolimus.

Avoid exposure to people with viruses such as chicken pox, shingles, and measles while using tacrolimus. If you believe you have been exposed to a virus, notify your doctor.

Ask your doctor about drinking alcohol while using tacrolimus.

Side effects
Side effects of tacrolimus may include tremors, nausea, trouble sleeping, stomach pain, headache, and diarrhea.

In rare cases, tacrolimus may increase your risk of developing lymphoma, serious infections such as polyomavirus and cytomegalovirus infections, diabetes, toxicity to the kidney and brain, high potassium levels, high blood pressure, and serious allergic reactions.

For more information about this treatment, visit:

Prograf (Tacrolimus) — U.S. Food and Drug Administration
https://www.accessdata.fda.gov/drugsatfda_docs/...